Suchergebnisse - "Bitossi, Alice"

PubPharm (15)

1

Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases : focus on Behçet's syndrome

enthalten in: Inflammopharmacology | 2020

von Silvestri, E. | Bitossi, A. | Bettiol, A. | +16

2

Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet’s syndrome

enthalten in: Inflammopharmacology | 2020

von Silvestri, E. | Bitossi, A. | Bettiol, A. | +16

3

Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet’s syndrome

enthalten in: Inflammopharmacology | 2020

von Silvestri, E. | Bitossi, A. | Bettiol, A. | +16

4

Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet’s syndrome

enthalten in: Inflammopharmacology | 2020

von Silvestri, E. | Bitossi, A. | Bettiol, A. | +16

5

Efficacy of anti-tumour necrosis factor-α monoclonal antibodies in patients with non-infectious anterior uveitis

enthalten in: Clinical and experimental rheumatology | 2019

von Fabiani, C. | Vitale, A. | Rigante, D. | +13

6

Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis : a retrospective observational study of 107 patients

enthalten in: Clinical rheumatology | 2019

von Fabiani, C. | Vitale, A. | Rigante, D. | +13

7

Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment : A Multicenter Retrospective Study

enthalten in: Mediators of inflammation | 2019

von Bitossi, A. | Bettiol, A. | Silvestri, E. | +14

8

Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis

enthalten in: Clinical rheumatology | 2019

von Fabiani, C. | Vitale, A. | Emmi, G. | +14

9

Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies

enthalten in: Clinical rheumatology | 2018

von Fabiani, C. | Sota, J. | Rigante, D. | +13

CommentIn: Eye (Lond). 2023 Aug;37(11):2197-2203. - PMID 36443499

10

Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies

enthalten in: Clinical rheumatology | 2018

von Fabiani, C. | Sota, J. | Rigante, D. | +13